Elsevier

Medical Hypotheses

Volume 49, Issue 3, September 1997, Pages 271-275
Medical Hypotheses

Endogenous digoxin-like immunoactivity and diabetes mellitus: facts and hypotheses

https://doi.org/10.1016/S0306-9877(97)90212-7Get rights and content

Abstract

Substances with digoxin- and ouabain-like immunoactivity (DLIA) are specific inhibitors of Na+-K+-ATPase which increase the total amount of intracellular stored calcium (Ca2+i). In diabetic patients, DLIA levels have been reported to be increased. Although this increase is probably secondary to sodium retention and volume expansion (induced in diabetic subjects by hyperinsulinemia and/or diabetic nephropathy), the question arises of whether it has pathophysiological consequences: namely, whether substances with DLIA, via their effect on Na+-K+-ATPase activity and Ca2+i stores, could in diabetic subjects facilitate development of hypertension and/or modulate insulin sensitivity or insulin secretion.

Clinical findings of correlations of DLIA to blood pressure, insulin levels and to degree of insulin resistance, together with experimental findings of decreased Na+-K+-ATPase activity, increased Ca2+i and decreased Mg2+i n both diabetic and hypertensioe subjects, support these hypotheses. However, the issue of whether or not these relations are causative and whether or not defects in intracellular milieu are primary or secondary to non-insulin-dependent diabetes mellitus has not been resolved yet. Moreover, pathogenesis of both diabetes mellitus and hypertension is multifactorial and includes many other factors. Therefore, further efforts should be made to elucidate the exact role of substances with DLIA in diabetes mellitus.

References (35)

  • B. Lichardus et al.

    On the role of digoxin-like substances, ANP, and AVP in natriuresis induced by hypertonic saline infusion in dogs

    J Cardiovascular Pharmacol

    (1993)
  • S.W. Chen et al.

    Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats

    Am J Hypertension

    (1993)
  • O. Giampietro et al.

    Increased urinary excretion of digoxin-like immunoreactive substance by insulin-dependent diabetic patients: a linkage with hypertension?

    Clin Chem

    (1988)
  • G. Andronico et al.

    Insulin resistance and endogenous digoxin-like factor in obese hypertensioe patients with glucose intolerance

    Acta Diabetologica

    (1992)
  • H. Takahashi et al.

    Digoxin-like immunoreactivity may contribute to hyperinsulinemiaassociated hypertension in patients with glucose intolerance

    J Cardiovascular Pharmacol

    (1993)
  • T. Wasada et al.

    Insulin resistance is associated with high plasma ouabain-like immunoreactivity concentration in NIDDM

    Diabetologia

    (1995)
  • E. Martinka et al.

    Digoxin-like immunoactivity in patients with diabetes mellitus and hypertension

    Am J Hypertension

    (1996)
  • Cited by (0)

    View full text